- Home
- PRQR vs DBL Comparison
PRQR vs DBL Comparison
Compare PRQR & DBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRQR
- DBL
- Stock Information
- Founded
- PRQR 2012
- DBL 2011
- Country
- PRQR Netherlands
- DBL United States
- Employees
- PRQR N/A
- DBL N/A
- Industry
- PRQR Biotechnology: Pharmaceutical Preparations
- DBL
- Sector
- PRQR Health Care
- DBL
- Exchange
- PRQR Nasdaq
- DBL Nasdaq
- Market Cap
- PRQR 309.5M
- DBL 280.4M
- IPO Year
- PRQR 2014
- DBL N/A
- Fundamental
- Price
- PRQR $1.43
- DBL $15.54
- Analyst Decision
- PRQR Strong Buy
- DBL
- Analyst Count
- PRQR 5
- DBL 0
- Target Price
- PRQR $9.80
- DBL N/A
- AVG Volume (30 Days)
- PRQR 583.9K
- DBL 61.0K
- Earning Date
- PRQR 05-08-2025
- DBL 01-01-0001
- Dividend Yield
- PRQR N/A
- DBL 8.67%
- EPS Growth
- PRQR N/A
- DBL N/A
- EPS
- PRQR N/A
- DBL N/A
- Revenue
- PRQR $20,235,014.00
- DBL N/A
- Revenue This Year
- PRQR $6.44
- DBL N/A
- Revenue Next Year
- PRQR N/A
- DBL N/A
- P/E Ratio
- PRQR N/A
- DBL N/A
- Revenue Growth
- PRQR 196.41
- DBL N/A
- 52 Week Low
- PRQR $1.07
- DBL $13.75
- 52 Week High
- PRQR $4.62
- DBL $15.70
- Technical
- Relative Strength Index (RSI)
- PRQR 50.71
- DBL 54.49
- Support Level
- PRQR $1.10
- DBL $15.13
- Resistance Level
- PRQR $1.26
- DBL $15.50
- Average True Range (ATR)
- PRQR 0.13
- DBL 0.30
- MACD
- PRQR 0.07
- DBL 0.03
- Stochastic Oscillator
- PRQR 73.47
- DBL 97.22
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.
About DBL DoubleLine Opportunistic Credit Fund of Beneficial Interest
Doubleline Opportunistic Credit Fund operates as a closed-end management investment company. Its investment objective is to seek a high total investment return by providing a high level of current income and the potential for capital appreciation. The Fund invests in debt securities, residential and commercial mortgage-backed securities, asset-backed securities, U.S. Government securities, corporate debt, international sovereign debt, and short-term investments.